annb0t
Top 20
Mesoblast Limited
NEW YORK, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the first quarter ended September 30, 2022.
The webcast will begin at 4.30pm EST, Tuesday, November 22; 8.30am AEDT, Wednesday, November 23, 2022. It can be accessed via: https://webcast.openbriefing.com/9143/
The archived webcast will be ...
>>> Read more: Mesoblast Financial Results and Corporate Update Webcast
NEW YORK, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the first quarter ended September 30, 2022.
The webcast will begin at 4.30pm EST, Tuesday, November 22; 8.30am AEDT, Wednesday, November 23, 2022. It can be accessed via: https://webcast.openbriefing.com/9143/
The archived webcast will be ...
>>> Read more: Mesoblast Financial Results and Corporate Update Webcast
